Advarra Announces Appointment of Jonathan E. Shough as President, Technology Solutions

Advarra, the market leader in clinical research practice management technology, regulatory review solutions, and research quality and compliance consulting services, announced today that it has named Jonathan E. Shough to the position of President, Technology Solutions.

Shough brings over 30 years of experience in information technology, including more than 20 years in the clinical research industry. He will be a member of the executive leadership team, reporting directly to Gadi Saarony, Advarra CEO. Shough will be responsible for managing Advarra’s technology business segment, driving product strategy and offerings, commercialization, and customer relationships.

Onathan E. Shough

“As we continue to evolve our technology offerings to empower sites and build connections across the clinical research ecosystem, Jonathan is a perfect fit to lead our efforts, and we’re pleased to welcome him to Advarra,” commented Saarony. “His proven expertise in developing and commercializing innovative technology solutions to improve the drug development process will further cement our position as the leader in practice management systems for clinical research and the preferred site technology partner for sponsors and CROs.”

Most recently, Shough was Senior Vice President and CIO, LabCorp Drug Development and GM Software Platforms, where he managed a large data and technology team and worked on several successful mergers and acquisitions. Prior to that, he held the position of Senior Vice President and Chief Data Officer at Syneos Health where he was responsible for developing and executing the data and commercialization strategy. At IQVIA, Shough served as executive director, IT, where he developed the technology go-to-market strategy and supported technology development. Earlier in his career, he held numerous information technology leadership positions in the financial and telecommunications industries. Shough attended Guilford College and is a US Marine Corps veteran.

“I am passionate about bringing the power of technology to improve the drug development process,” Shough said. “I’m excited to join Advarra and help progress their strategic vision to connect sites, CROs, and sponsors through technology.”

 

SourceAdvarra

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.